Searched for
ADJUVANTED VACCINE
Worried about recent rise in COVID-19 cases? Here's how to protect yourself without getting a jabAmidst rising COVID-19 cases in Asia, Yale University researchers have discovered that nasal vaccine boosters offer a safer and more target...- France's Sanofi signs COVID-19 vaccine deal with NovavaxSanofi and Novavax partnered for a COVID-19 vaccine deal. Novavax will receive $1.2 billion in milestones. Sanofi will take an equity stake...
- Oxford University, Serum Institute of India tie-up delivers 'high efficacy' malaria vaccineThe R21/Matrix-M vaccine, leveraging Novavax's adjuvant technology, has been approved for use in children aged 5 to 36 months - the age gro...
- Cell-based or 'adjuvanted' vaccines: Which flu shot should you choose?An annual flu vaccine is recommended for adults and children six months and older.
- CEPI partners Bharat Biotech to develop 'variant-proof' vaccine"Our expertise in product development and innovation, especially with novel adjuvants and platform technologies will add to the strong part...
- Sanofi, GSK receive nod for Phase 3 trial of COVID-19 vaccine candidate in IndiaThe design of the Phase 3 study, conducted across a broad diversity of geographies, also allows evaluation of the efficacy of the candidate...
- Covaxin neutralises both Alpha, Delta variants of Covid effectively, research by top US health institute findsThe vaccine has so far been given to around 25 million recipients in India and elsewhere. Interim results from Covaxin's Phase 3 trial have...
- Novavax and the recombinant protein vaccine: What you need to knowThe recombinant protein vaccine develops the body’s immunity against the coronavirus by using the virus' spike proteins. Used by Novavax in...
- Megalab gets Rs 300-cr seed fund to develop Ayurveda-based Covid vaccineThe Mumbai-based Megalab, set up last April by the council to drive the fight against the pandemic with ideas and money, will also be impor...
- Biological E gets nod for Phase III trial of its COVID-19 vaccine candidateIts candidate includes an antigen developed by the Texas Childrens Hospital Center for Vaccine Development and in- licensed from BCM Ventur...
- Bharat Biotech ramps up Covaxin production capacity to 700 mn doses per annumThe technology transfer process is well underway and IIL has the capabilities and expertise to manufacture inactivated viral vaccines at co...
- Covaxin safe, may be superior to similar vaccines: LancetIndia’s first indigenous Covid-19 vaccine Covaxin, codenamed BBV152, is safe, immunogenic and has no serious adverse effects, medical journ...
- GSK sees lower profit this year, split plans on trackThe world's biggest vaccine maker by sales said on Wednesday it expected adjusted earnings to fall by a mid- to high-single digit percentag...
- Biological E gets DGCA nod to begin the next phase of trials for its COVID-19 vaccineThis vaccine candidate includes an antigen that was in-licensed from BCM Ventures, which is an integrated commercialisation team of Baylor ...
- Bharat Biotech to use ViroVax's adjuvant in Covid vaccineBharat Biotech has collaborated with ViroVax to use its adjuvant for boosting the immune response while also providing long-lasting immunit...
- Sanofi and GSK launch trial for COVID-19 protein-based vaccineSanofi and GSK said in a joint statement on Thursday they had started the "Phase 1/2" trial for their adjuvanted COVID-19 vaccine, which th...
- GSK will price vaccine responsibly: Emmanuel Hanon, R&D HeadGSK said it was not expecting to profit from its collaborations on a vaccine candidate during the pandemic as the company rushes to offer 1...
- GSK, Sanofi team up to bring out Covid-19 vaccineTwo of the world's largest vaccine manufacturers, Sanofi and GlaxoSmithKline, are coming together to work on a Covid-19 vaccine, which if i...
- Novartis, Sanofi seek new vaccine to fight mutating fluNovartis and Sanofi-Aventis are among drug-makers searching for new weapons against influenza viruses that evade protection from existing v...
- Glaxo's bird flu drug to hit market next yearA bird flu vaccine for humans that uses only a very low dose of active ingredient has proved effective in clinical tests and could be mass ...
Load More
